USCCB Statement on the Supreme Court’s Abortion Pill Decision

| 06/13/2024

By: The Good Newsroom

“Today’s Court ruling on procedural grounds will continue to put the health of women and girls at risk”

Boxes of Mifepristone, the first pill in a medical abortion, are seen at Alamo Women's Clinic in Carbondale, Illinois, April 20, 2023.
Boxes of Mifepristone, the first pill in a medical abortion, are seen at Alamo Women's Clinic in Carbondale, Illinois, April 20, 2023. The U.S. Supreme Court dismissed a challenge to the rules for the availability of the abortion drug mifepristone in a unanimous decision on June 13, 2024. (OSV News photo/Evelyn Hockstein, Reuters)

LOUISVILLE, Kentucky — In response to the decision by the Supreme Court of the United States today on FDA v. Alliance for Hippocratic Medicine the U.S. Conference of Catholic Bishops (USCCB) offered the following statement from its spokesperson, Chieko Noguchi, executive director of public affairs.

“Today’s Court ruling on procedural grounds will continue to put the health of women and girls at risk. As the USCCB’s pro-life chairman has said, abortion is not health care. The Church will continue to advocate for women’s health and safety, and to lovingly serve mothers in need.”

De acuerdo con las normas de la arquidiócesis sobre el respeto al abuso sexual de menores, esta información se provee para asegurar que nuestros niños permanezcan seguros.

By:

The Good Newsroom

| 08/01/2025

In keeping with archdiocesan policy regarding sexual abuse of minors, this is provided to ensure that our children remain safe and secure.

By:

The Good Newsroom

| 08/01/2025

The Vatican's Dicastery for Saints' Causes confirmed July 31 that Pope Leo XIV had accepted an "affirmative opinion" by cardinals and bishops that the Church's 38th title of doctor of the Church should be conferred on the British saint.

By:

Our Sunday Visitor

| 08/01/2025

Error, group does not exist! Check your syntax! (ID: 7)